President Message   |   Committee   |   History   |   Membership   |   Contact Us   |   Feedback & Enquiry   |   Home

Advanced Search

                    Forgot your password?
Home » Media Centre » Press releases »  

Press Release: ASAP Issues Statement Regarding PCV-10 Procurement In The Philippines

For Immediate Release:
14 November 2014
14 November – Manila: As concern spreads regarding the government’s 2012 procurement of pneumocccal disease vaccines for the National Immunisation Programe, an official statement has been issued to the press by the Asian Strategic Alliance for Pneumococcal disease prevention (ASAP), a scientific working group which makes recommendations on pneumococcal disease prevention in Asia.
»

Pediatric Medical Organizations Call on Global Community to Protect Children From War in Syria

Since the conflict in Syria began three years ago, millions of children have been forced from their homes, witnessed horrific abuse and violence, and have been deprived of basic access to education and health care. The International Pediatric Association (IPA) join other humanitarian organizations in calling on leaders to end the violence against children in Syria.
»

Child Rights: Medical, Societal and Policy Perspectives

Press Statement:
The judicial outcome of the recent cases of statutory rape has caused public outcry, disbelief and anger. The Attorney-General's Chambers and its chief Tan Sri Abdul Gani Patail, professionals and laypersons alike have voiced their views strongly in the mainstream and online media.
»

Rotavirus vaccination - WHO does not recommend any change to use of Rotarix vaccine in developing countries

Following announcements today by the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) regarding use of the rotavirus vaccine, Rotarix, the World Health Organization (WHO) encourages all countries using the vaccine to carefully consider the significant benefits of continued use of the vaccine in any decisions about further use.
»

European Medicines Agency statement on new information on Rotarix oral vaccine

The European Medicines Agency is aware of new information reported by the manufacturer of Rotarix, GlaxoSmithKline Biologicals, relating to the unexpected presence of DNA of a non-disease causing viral strain in batches of the oral vaccine. Through its own tests, the company has confirmed the finding of DNA originating from porcine circovirus type 1.
»

Components of Extraneous Virus Detected in Rotarix Vaccine; No Known Safety Risk

FDA Recommends Clinicians Temporarily Suspend Use of Vaccine as Agency Learns More
FDA is recommending that healthcare practitioners temporarily suspend use of the Rotarix vaccine for rotavirus immunization in the United States while the agency learns more about components of an extraneous virus detected in the vaccine. There is no evidence at this time that this finding poses a safety risk.
»

GlaxoSmithKline statement on new information relating to manufacture of Rotarix (rotavirus vaccine)

GlaxoSmithKline (GSK) today confirmed that it has notified regulatory authorities of the presence of material from a virus called PCV-1 in its oral rotavirus vaccine, Rotarix™. PCV-1 does not multiply in humans and is not known to cause illness in humans.1, 2. It is found in everyday meat products and is frequently eaten with no resulting disease or illness.
»
Home | Disclaimer |  Sitemap | Contact Us | Credits |

©Copyright © Malaysian Paediatric Association - MPA   2010    All rights reserved.